INTRODUCTION
genes. Whereas the functional data described above are important in establishing a link between Pdx1 and the expression of specific genes, these studies do not address the issue of whether Pdx1 is involved in a transcriptional complex that directly controls the expression of these genes. Only circumstantial evidence suggests direct involvement: specific elements within the promoter regions of these ß-cell specific genes have been demonstrated to be bound by Pdx1 in in vitro electrophoretic mobility shift assays (EMSAs) (12, 14, 17, (19) (20) (21) . Pdx1 is a homeodomain-containing transcription factor and demonstrates sequence-specific DNA binding (to TAAT-containing motifs), similar to the homeobox genes of Drosophila (22, 23) . Since Pdx1 functions as an activator of gene transcription, it is therefore believed to activate gene expression by binding to upstream TAAT sequences (24) .
Critical evidence that is lacking to establish Pdx1 as an immediate regulator of ß-cell gene expression includes the demonstration that Pdx1 is physically associated with ß-cell gene promoters in vivo. An emerging theme in transcriptional regulation is the influence of chromatin structure within the nuclear environment on both DNA binding by transcription factors as well as the resultant regulation of transcription (25, 26) . The highly compacted nature of chromatin could conceivably hinder accessibility to some DNA binding sites but not to others, notwithstanding that these sites may display equal affinity for a given factor in vitro (27, 28) . Thus, we cannot necessarily predict from studies in vitro which promoters Pdx1 binds in vivo.
To determine which promoters Pdx1 might directly regulate in vivo, we Chakrabarti, et al. performed chromatin immunoprecipitation (ChIP) assays using Pdx1 antiserum and chromatin from various cell lines, and followed this by quantitative real-time PCR to determine the relative distribution of co-immunoprecipitated promoters.
We performed these studies in vivo using a non-ß-cell line (NIH3T3) and a ß-cell line (ß-TC3), as well as in an in vitro setting for comparison. We demonstrate that Pdx1 is associated with several, but not all, ß-cell specific genes in vivo. We show further that there is a significant difference in the binding distribution of Pdx1 to promoters in vitro and in vivo as well as in ß-cells and non-ß-cells. Our findings suggest a model in
EXPERIMENTAL PROCEDURES

Cell culture and transient transfections
The mouse cell lines, ß-TC3 and α-TC1.6, were maintained in high glucose
Dulbeccos modified Eagle medium (DMEM) supplemented with 15% horse serum, 2.5% fetal bovine serum, and 1% penicillin/streptomycin. The mouse fibroblast cell line, NIH3T3, was maintained in high glucose DMEM supplemented with 10% calf serum and 1% penicillin/streptomycin. For transient mammalian cell transfections, 5x10 5 NIH3T3 cells were plated on 10 cm plates one day prior to transfection. A total of 8 µg of either the CMV promoter-driven expression vector pBAT12Pdx1 (12) or the parent vector without insert (pBAT12) was mixed with 12 µl of Transfast ® reagent (Promega), and transfections were performed according to the manufacturer´s protocol. Cells were harvested for chromatin immunoprecipitation assays or Western blots approximately 48 h later.
Electrophoretic mobility shift assays (EMSAs).
Single stranded oligonucleotide probes were 5 end labeled with [γ 32 P]-ATP using T4 polynucleotide kinase. Labeled oligonucleotides were column purified and annealed to an excess of complementary strand. EMSA buffers and conditions were described previously (29) . Where supershift assays were performed, 1 µl of Pdx1 antiserum (provided by Dr. M. German) was also added. Oligonucleotide fragments were derived from elements of each promoter known to be important in the Chakrabarti, et al.
transcriptional regulation of that gene and that contained a Pdx1 binding motif (TAAT).
The Albumin promoter oligonucleotide was selected based entirely upon the presence of a TAAT motif. The following oligonucleotide probes were used (top strands shown).
Mouse I insulin promoter (A3/A4 element, ref. (12, 30) ):
utated mouse I insulin promoter (A3/A4 element):
ouse Glut2 promoter (Glut2TAAT motif, ref. (14)):
ouse Glucokinase promoter (UPE1 element, ref. (31) ):
ouse Albumin promoter:
5´-TGAAGCTCAGGTTTAATTCCCAGTCACAT-3Ḿ
ouse Glucagon promoter (G1 element, ref. (32) ):
hromatin immunoprecipitation assays.
Chromatin immunoprecipitation assays were performed as described in the literature (33), with some modifications. A total of 1x10 7 NIH3T3 cells (from 3 confluent 10 cm plates) or 2.5x10 7 ß-TC3 or a-TC1.6 cells (from 2 confluent 10 cm plates) were treated with 1% formaldehyde by adding 0.27 ml of 37% formaldehyde directly to 10 ml of culture medium. After incubating in formaldehyde for 10 min. at Chakrabarti, et al.
room temperature, glycine was added to a final concentration of 0.125 M. The cells were then suspended in 0.6 ml of lysis buffer (50 mM Tris-Cl, pH 8.1 containing 1% Triton X-100, 0.1% deoxycholate, 150 mM NaCl, and 5 mM EDTA) plus protease inhibitors (leupeptin, PMSF, and aprotinin) and subject to sonication (using a Fisher Scientific model 60 sonic dismembrator with a microtip at a setting of 10). Ten 5-sec. sonication pulses were required for NIH3T3 cells and fifteen 5-sec. pulses were required for ß-TC3 and α-TC1.6 cells to shear chromatin to 1000 bp fragments. The effectiveness of shearing was confirmed by incubating a 10µl aliquot of the extract at 65 ÚC for 3 h (to reverse crosslinks) and subsequently subjecting it to electrophoresis on a 1% agarose gel. 0.25 ml aliquots of the clarified extracts were diluted to 1 ml in lysis buffer containing protease inhibitors and then incubated with either 5 µl anti-Pdx1 antiserum or normal rabbit serum (25 µl was also aliquoted separately and stored for later PCR analysis as 10% of the input extract). Incubations occurred overnight at 4 ÚC on a rocking platform, after which 40 µl of protein A agarose slurry (Santa Cruz Biotechnology) and 2 µl of a 10 mg/ml herring sperm DNA solution (Sigma) were added, and incubation was continued an additional one hour.
The agarose was pelleted by centrifugation, and the pellets were washed consecutively with 1 ml of lysis buffer, lysis buffer plus 500 mM NaCl, lysis buffer plus 0.25 M LiCl, and Tris/EDTA. DNA and protein were eluted from the pellets by incubating the pellets two times in 0.25 ml of elution buffer (0.1 M NaHCO3 with 1% SDS and 20 µg/ml herring sperm DNA, and protein-DNA crosslinks were reversed by incubating at 65 ÚC for 3 h. DNA and protein were ethanol precipitated overnight at 20 
In vitro immunoprecipitations.
In vitro reactions were set up similar to EMSA reactions. Briefly, each reaction consisted of 10 µg poly dI/dC, 100 µg BSA, 1 fmol of each promoter (see below), and 10 µg of either pBAT12-or pBAT12Pdx1-transfected NIH3T3 nuclear extract in a 200 µl solution of 10 mM HEPES, pH 7.9 with 75 mM KCl. The concentration of promoters in the reaction (5x10 -12 M each) was chosen such that the percentage of any given promoter that was immunoprecipitated was in the range 0.1-1.0% of the input quantity (to match the results obtained in the ChIP assays, see later). The promoters used in these reactions (ranging in size from 100-250 bp) were excised from their respective pCR2.1 vectors by digestion with EcoRI (see below for details on the construction of these vectors). The reactions were allowed to proceed at room temperature for 15 min., after which formaldehyde was added to a final concentration 1%, and the reactions were incubated an additional 5 min. Glycine was then added to a final concentration of 0.125 M. 90 µl aliquots were removed and diluted to 1 ml using lysis buffer and then Chakrabarti, et al.
Real-time PCR quantitation of co-immunoprecipitated promoter fragments.
The relative proportions of co-immunoprecipitated promoter fragments were determined based on the threshold cycle (T C ) value for each PCR reaction. The T C value is determined as the cycle at which fluorescence rises 10 times above the mean standard deviation of background levels in all reaction wells. Real time PCR data analysis followed the methodology described in a recent report (34) . For every promoter studied, a T C value was calculated for each sample by subtracting the T C 
Western blot analysis.
Nuclear extracts from NIH3T3, ß-TC3, and a-TC1.6 cells were prepared from single, confluent 10 cm plates of cells according to methods described previously (35) . 5 µg of nuclear extract were subject to Western blot analysis after electrophoresis on a 4-20% gradient SDS-polyacrylamide gel using Pdx1 antiserum. Western blots were visualized using the ECL-Plus ® system (Amersham). Western blots from immunoprecipitated samples proceeded similarly, except that 20 µl of protein following elution (in 100 µl of Laemmli buffer) from the protein A agarose was used in the analysis.
Chakrabarti, et al.
RESULTS
Pdx1 binds to TAAT-containing DNA sequences in vitro.
Several studies have documented the sequence-specific DNA binding properties of Pdx1 (12, 13, 36) . To demonstrate that Pdx1 can bind to key promoter elements from a variety of ß-cell specific genes, we performed EMSAs ( protein is obtained from ß-cell nuclear extract (ß-TC3 cells) or from an in vitro translation system using rabbit reticulocyte lysate (data not shown).
Chromatin Immunoprecipitation of Pdx1-associated Promoters
Since the data in Fig. 1 
demonstrate poor promoter selectivity by Pdx1 in vitro,
we sought to determine the distribution of Pdx1 promoter binding in vivo by use of the chromatin immunoprecipitation (ChIP) assay. The ChIP assay is a recently developed method that has typically been used to assess the association of abundant histone complexes with specific genes (33) . When the ChIP assay is coupled to PCR-based detection methods, however, the association of far less abundant transcription factor complexes with specific genes can be reliably assessed (38) . To compare the in vivo ChIP results from the cell lines, immunoprecipitation assays were also performed in an in vitro environment, where nuclear extracts from NIH3T3/Pdx1 and NIH3T3/EV cells were incubated with an equimolar mixture of cloned, 100-250 bp fragments of the promoters being analyzed in this study (see Table   1 ). The primary difference between the in vitro reactions and the in vivo experiments is the that the promoters in vitro are not associated with histones or other modifying Chakrabarti, et al.
proteins and therefore have no chromatin-like compaction. Since the Pdx1 in these in vitro samples was from nuclear extract, we assume that any ubiquitous interacting proteins that might affect DNA binding by Pdx1 are also present in these reactions.
The cell lines and in vitro reactions were treated with 1% formaldehyde to crosslink proteins to chromatin, and the cell line samples were subsequently sonicated to shear the chromatin to an average of length of 1000 bp (Fig. 2c) . All samples were then subject to immunoprecipitation using either Pdx1 antiserum or normal rabbit serum. To confirm that Pdx1 was successfully immunoprecipitated from samples containing the protein, we performed Western blots for Pdx1 on the final immunoprecipitated samples as shown in Fig. 2d .
Pdx1 associates with only a subset of promoters in NIH3T3 cells in vivo, but predictably to all TAAT-containing promoters in vitro.
Immunoprecipitated samples were subject to quantitative real-time PCR using primers to amplify the ß-cell gene promoters mouse I Insulin, Glut2, IAPP, Glucokinase, Pdx1, and Pax4, and the non-ß-cell gene promoters Glucagon and
Albumin. Primer pairs ( As a negative control for in vivo studies, the Albumin promoter fragment was chosen as a random genomic element containing Pdx1 binding sites, but not believed to be Chakrabarti, et al.
regulated by Pdx1. As a negative control for in vitro studies, a fragment of the Glucagon promoter (referred to as Glucagon region 1, see Table 1 ) was chosen, which contained no TAAT sequences. Fig. 3 shows that PCR amplification of all promoter fragments from sheared NIH3T3 genomic DNA results in homogenous products of expected molecular weights.
Co-immunoprecipitated promoters were analyzed by quantitative, real-time PCR using SYBR Green I methodology. SYBR Green I is an intercalating dye that stoichiometrically incorporates into double-stranded DNA, resulting in fluorescence emission at 530 nm during early cycles of PCR that is proportional to the amount of DNA template present in the sample (41) . As an example, As expected, the data in Fig. 5 show that no significant coimmunoprecipitation of promoters occurs from NIH3T3/EV cells or nuclear extract (since no Pdx1 protein is expressed).
Promoter targeting by Pdx1 in ß-TC3 cells.
To determine the distribution of promoter binding by endogenous Pdx1 in a ß-cell-derived cell line, we performed ChIP assays in ß-TC3 cells. As a negative control for these studies, we also performed ChIP assays in α-TC1.6 cells, an α-cell-derived cell line that does not express Pdx1 (see Fig. 2b ). Chakrabarti, et al.
Promoter binding by Pdx1 in vivo depends upon cell type.
To directly compare the promoter binding distributions by Pdx1 in NIH3T3/Pdx1 cells, ß-TC3 cells, and the in vitro binding assay, we normalized the fold-differences observed for each promoter to the fold-difference observed for the Albumin promoter in the same experiment (a promoter not believed to be bound or regulated by Pdx1). These normalized data are presented in Table 2 . Three striking findings arise upon analysis of these data. First, binding to promoters with TAAT sequences in vitro displays an overall uniformity, with fold-differences ranging from Lastly, the data in Table 2 demonstrate that Pdx1 binds significantly less to the Glucokinase promoter in ß-TC3 cells than in NIH3T3/Pdx1 cells (2.8-vs. 17.8-fold over controls), suggesting that the ß-cell nuclear environment may also function to limit binding of Pdx1 to certain ß-cell-specific genes. To determine if nuclear proteins in ß-TC3 nuclear extract might limit or prevent accessibility of Pdx1 to key Glucokinase Chakrabarti, et al.
regulatory regions, we performed EMSAs using nuclear extract from ß-TC3 cells, α-TC1.6 cells, and NIH3T3 cells and an oligonucleotide probe corresponding to a regulatory upstream promoter element at ˘206 to ˘220 of the Glucokinase promoter (see ref. (31) . As shown in Fig. 7 , Pdx1 from ß-TC3 nuclear extract binds to the Glucokinase promoter element to at least the same extent as observed in NIH3T3/Pdx1 nuclear extract (expression levels of Pdx1 in these extracts did not differ significantly, see Fig.   2b ). This result suggests that structure of chromatin in ß-TC3 cells, rather than the presence of inhibitory factors, likely accounts for the lower association of Pdx1 with the Glucokinase promoter in this cell type.
Chakrabarti, et al. qualitative ChIP that Pdx1 interacts with the Area I region in ß-TC3 cells. Our ChIP studies confirm these findings, but extend upon them by demonstrating that this interaction (similar to the Insulin promoter interaction) is more robust in ß-cells than non-ß-cells by a factor of nearly 4-fold (Table 2 ). This enhanced selectivity in ß-cells might explain how the broad expression of Pdx1 in the early developing pancreas (5) becomes progressively amplified in ß-cells as differentiation of cell types proceeds.
Glucokinase promoter. Although cell line studies have suggested a role for Pdx1 in the activation of the Glucokinase gene (18, 19) , recent studies involving inactivation of the Pdx1 gene in both animal and cell line models have reported contradictory findings on this issue (10, 15) . These disparate results might be explained by the differences in cell line models used to study this regulatory phenomenon. In this regard, our findings demonstrate a significant diversity in the ability of Pdx1 to bind to the Glucokinase promoter in vivo, since we observed robust binding in NIH3T3/Pdx1 fibroblasts and almost no binding in ß-TC3 cells (Figs. 5 and 6 and Table 2 ). Since we and others (19) have demonstrated that no protein factors exist in ß-cell nuclear extract to prevent the binding of Pdx1 to Glucokinase promoter elements (see Fig. 7 
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Chakrabarti, et al. Table 1 . In quantitative real-time PCR the immunoprecipitated samples are normalized to input (total genomic DNA) quantities for any given promoter, thus correcting for any differences in both input quantity and efficiency of promoter amplification.
Chakrabarti, et al. Where indicated, numbers represent the position of the amplified fragment relative to the known transcriptional start site for the gene. a Fold-differences for each promoter in Figs. 5 and 6 were divided by the folddifference for the Albumin promoter in the same study to correct for ˆbackgroundb inding. Data for NIH3T3/EV cells and α-TC1.6 cells were omitted, since no significant fold-differences were observed in these cell lines.
b To highlight the uniformity of Pdx1 binding in vitro, numbers in parentheses represent the normalized fold differences divided by the number of Pdx1 binding sites contained within the individual promoter fragments (see Table 1 ). Data shown are for in vitro reactions using NIH3T3/Pdx1 nuclear extract only.
